Back to AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

All insiders

14 insiders

InsiderRole% of sharesShares heldLast trade
Martin Patricia A.Director0.04%16,905Mar 19, 2026
Aziz KabeerDirector0.14%52,479Mar 19, 2026
Prior Stephen DavidChief Strategy Officer0.16%59,086Jan 6, 2026
Williams Sarah JoannePrincipal Accounting Officer0.18%66,848Mar 3, 2026
Marks Gilbert LynnDirector0.20%75,309Mar 19, 2026
Day LucyChief Financial Officer0.31%118,363Mar 19, 2026
Chanda SanjayChief Development Officer0.31%118,823Mar 19, 2026
Eizen Joshua MSee Remarks0.55%207,499Mar 19, 2026
Eric EasomChief Executive Officer · Director0.98%368,630Mar 19, 2026
FitzPatrick Margaret MDirectorMar 19, 2026
Readnour Robin ShaneDirectorMar 19, 2026
Spigelman Melvin KDirectorMar 19, 2026
Wong StephanieDirectorMar 19, 2026
Zakrzewski Joseph SDirectorMar 19, 2026
← PrevPage 1 of 1Next →